Vardenafil Hydrochloride Tablet
Product Images NDC 71335-9689

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 71335-9689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713359689)

Vardenafil Hydrochloride Tablets 20 mg oral tablets labeling from Bryant Ranch Prepack. The label indicates a package size of 30 tablets. It includes storage instructions, child safety warnings, and repackaging and manufacturing information. The NDC is prominently shown as 71335-9689-1.*

FDA Label Image

Chemical Structure (Vardenafil Figure 1)

Chemical structure of Vardenafil Hydrochloride showing its molecular framework, including rings, bonds, and attached groups, as represented in the product data for the 20 mg oral tablet by Bryant Ranch Prepack.*

FDA Label Image

Figure 1 (Vardenafil Figure 2)

A set of three line graphs showing mean maximal changes in systolic blood pressure, diastolic blood pressure, and heart rate over time related to the timing of Vardenafil treatment before NTG administration. The x-axis represents time intervals (24h, 8h, 4h, 1h), and the y-axis displays the measured changes in mmHg for blood pressure and beats per minute for heart rate, with error bars indicating variability.*

FDA Label Image

Figure 2 (Vardenafil Figure 3)

A line graph depicting mean change in mmHg over a 6-hour period comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours, and the y-axis shows mean change in mmHg. Four data series are plotted using different markers for placebo and Vardenafil in each condition.*

FDA Label Image

Figure 3 (Vardenafil Figure 4)

A line graph comparing mean change in mmHg over 6 hours for placebo and vardenafil 5 mg under simultaneous and 8-hour separation conditions. The x-axis represents time in hours, and the y-axis shows mean change in blood pressure. Four lines distinguish the four conditions using different markers and line styles.*

FDA Label Image

Figure 4 (Vardenafil Figure 5)

Line graph showing mean change in mmHg over time in hours. Four data series compare placebo (Stage 1 and Stage 2) and Vardenafil doses (10 mg and 20 mg). Vardenafil groups show a greater reduction in mean values over 6 hours compared to placebo.*

FDA Label Image

Figure 5 (Vardenafil Figure 6)

A line graph showing mean change in blood pressure (mmHg) over time (hours) for placebo and Vardenafil Hydrochloride dosages of 5 mg and 10 mg. The graph includes four data series representing placebo in two stages and Vardenafil at 5 mg and 10 mg, depicting variations in blood pressure changes measured from 0 to 6 hours post-dosing.*

FDA Label Image

Figure 6 (Vardenafil Figure 7)

A line graph titled 'TERAZOSIN' showing mean change in mmHg over a 6-hour period. It compares placebo, 10 mg vardenafil, and 20 mg vardenafil under two conditions: 6-hour separation and simultaneous administration. The x-axis represents time in hours (0 to 6), and the y-axis represents mean change in mmHg, ranging approximately from -30 to +10.*

FDA Label Image

Figure 7 (Vardenafil Figure 8)

A line graph titled 'Tamsulosin' showing mean change in mmHg over 6 hours. The x-axis represents time in hours, and the y-axis shows mean change in mmHg. The graph compares placebo, 10 mg Vardenafil, and 20 mg Vardenafil with two conditions: 6-hour separation and simultaneous administration, each represented by different line styles and markers.*

FDA Label Image

Figure 8 (Vardenafil Figure 9)

A line graph depicting plasma concentration (µg/L) of Vardenafil Hydrochloride over time (hours) post administration. The plasma concentration peaks around 1 hour and gradually declines to near zero by 24 hours, with error bars indicating variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.